Intellectual Property India Publishes Patent Application for 'Combination Of Polyamine Pathway Inhibitor Drug And Proline/Arginine Diet Restriction' Filed by Universitat Zurich

MUMBAI, India, Aug. 1 -- Intellectual Property India has published a patent application (202517059026 A) filed by Universitat Zurich, Zurich, on June 19, for 'combination of polyamine pathway inhibitor drug and proline/arginine diet restriction.'

Inventor(s) include Morscher, Raphael.

The application for the patent was published on Aug. 1, under issue no. 31/2025.

According to the abstract released by the Intellectual Property India: "In one aspect, the invention relates to the use of difluoromethylornithine (DFMO) in treatment of cancer. The drug is administered to a patient undergoing a dietary regimen and/or drug treatment that is designed to reduce a plasma level of proline, arginine, or both."

The patent application was internationally filed on Nov. 20, 2023, under International application No.PCT/EP2023/082430.

Disclaimer: Curated by HT Syndication.